Glycopyrrolate

NDC 55150-295 · AuroMedics Pharma LLC

Generic nameGlycopyrrolate

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS

Active ingredient(s)GLYCOPYRROLATE

Strength.2 mg/mL

Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA]

Marketing categoryANDA

Packages

55150-295-20 — 25 VIAL, MULTI-DOSE in 1 CARTON (55150-295-20) / 20 mL in 1 VIAL, MULTI-DOSE

FDA lists these products with the same active ingredient.

51672-5316 — Glycopyrrolate Oral Solution, 51754-6000 — glycopyrrolate, 51754-6001 — glycopyrrolate, 51754-6013 — glycopyrrolate, 51754-6015 — glycopyrrolate, 55111-648 — Glycopyrrolate, 55111-649 — Glycopyrrolate, 55150-292 — Glycopyrrolate, 55150-293 — Glycopyrrolate, 55150-294 — Glycopyrrolate, 55154-7475 — Glycopyrrolate, 59651-435 — GLYCOPYRROLATE, 60429-666 — GLYCOPYRROLATE, 60687-458 — GLYCOPYRROLATE, 62135-734 — Glycopyrrolate, 62135-735 — Glycopyrrolate, 62135-961 — Glycopyrrolate, 62332-607 — Glycopyrrolate, 62332-627 — Glycopyrrolate, 62332-628 — Glycopyrrolate, +177 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.